finacialnews-logo-final-01 (2).png
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
February 15, 2024 08:45 ET | FN Media Group LLC
PALM BEACH, Fla., Feb. 15, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Numerous reports indicate that the fibromyalgia treatment market is positioned to continue to grow at a...
Healis selected to present at key biotechnology and neuroscience investor conferences in Amsterdam, New York, and San Diego
February 12, 2024 08:00 ET | Healis Therapeutics
Healis' clinical program developing BoNT/A neuromodulator proteins has the potential to transform care for over 280 million patients with depression.
fundamental pharma.png
FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic Lateral Sclerosis
February 07, 2024 08:00 ET | Fundamental Pharma GmbH
PRESS RELEASE FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine using a TwinF Interface Inhibitor for the Treatment of Amyotrophic...
NodThera_logo.jpg
NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer
February 05, 2024 07:00 ET | NodThera
Se NodThera Ltd (“NodThera” or the “Company”) NodThera Announces Appointment of Dr. Thomas Jaecklin as Chief Medical Officer BOSTON, MA, February 5, 2024 - NodThera, a leading clinical-stage...
FDA Clears Magstim TMS Horizon 3.0 with StimGuide Pro Treatment for Patients with Depression, Obsessive Compulsive Disorder, Anxious Depression
FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro
January 30, 2024 09:18 ET | Magstim EGI
FDA clears Magstim TMS System Horizon 3.0 with StimGuide Pro providing treatment for patients patients with depressive or obsessive-compulsive conditions
Webinar Presenter
PTSD: The Brain Basis of Susceptibility - A Free Webinar from the Brain & Behavior Research Foundation
January 03, 2024 09:04 ET | Brain & Behavior Research Foundation
New York, Jan. 03, 2024 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “PTSD: The Brain Basis of Susceptibility” on Tuesday, January 9, 2024, at...
logo.png
Nexstim receives Nexstim NBS System 5 order from Europe for Neurosurgery and Neuroscience Use
December 22, 2023 02:00 ET | Nexstim Oyj
Press release, Helsinki, 22 December 2023 at 9 AM (EET) Nexstim receives Nexstim NBS System 5 order from Europe for Neurosurgery and Neuroscience Use Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company")...
Catalyst Pharmaceutical logo
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies
December 05, 2023 08:03 ET | Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced its inclusion in Forbes' esteemed list of America's Most...
Vectorpng.jpg
alwaysAI Announces Strategic Partnership With Dr. Gabriel A. Silva, Professor of Neuroscience and Bioengineering at the University of California San Diego
November 27, 2023 13:12 ET | alwaysAI
alwaysAI Announces Strategic Partnership With Dr. Gabriel A. Silva, Professor of Neuroscience and Bioengineering at the University of California San Diego
SNS-INSIDER-300X300.jpg
Neuroscience Market to Hit USD 65.8 Billion by 2030 Owing to Increasing Prevalence of Neurological Disorders and Collaborative Research Initiatives | Research by SNS Insider
November 20, 2023 09:00 ET | SNS Insider pvt ltd
Pune, Nov. 20, 2023 (GLOBE NEWSWIRE) -- “The SNS Insider report indicates that the size of Neuroscience Market was projected to be USD 42.6 billion in 2022, with an anticipated growth to USD 65.8...